CD274 and neoplasm: PD-L1 expression was reported as < 1%, 1–5%, and > 5% based on the percent of positive cytoplasmic and/or membranous expression of PD-L1 by tumor cells (TC-PD-L1) and immune cells (IC-PD-L1) separately.